Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-2 as a therapeutic agent.

N S Sule1, R P Nerurkar, S Kamath

  • 1Department of Pharmacology, TN Medical College and BYL Nair Hospital, Mumbai.

The Journal of the Association of Physicians of India
|February 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Does prehospital time affect survival of major trauma patients where there is no prehospital care?

Journal of postgraduate medicine·2017
Same author

Effect of adjunctive use of green tea dentifrice in periodontitis patients - A Randomized Controlled Pilot Study.

International journal of dental hygiene·2015
Same author

Radiological approach to a child with hip pain.

Clinical radiology·2013
Same author

Decision support system for diabetic retinopathy using discrete wavelet transform.

Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2013
Same author

Impact of obesity severity and duration on pancreatic β- and α-cell dynamics in normoglycemic non-human primates.

International journal of obesity (2005)·2012

Interleukin-2 (IL-2), a cytokine, stimulates immune cells and is used therapeutically for HIV/AIDS, melanoma, and renal cell carcinoma. While effective, its main side effect is capillary leak syndrome.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Interleukin-2 (IL-2) is a regulatory cytokine produced by T(H) lymphocytes and other cells.
  • It stimulates T lymphocyte proliferation and cytotoxicity, and enhances immune cell activities.

Purpose of the Study:

  • To review the therapeutic applications and adverse effects of Interleukin-2 (IL-2).
  • To highlight the role of IL-2 in managing various diseases.

Main Methods:

  • Recombinant DNA technology for large-scale IL-2 production.
  • Clinical studies evaluating IL-2 in HIV/AIDS, cancer, and autoimmune diseases.

Main Results:

  • IL-2 demonstrates therapeutic value in HIV/AIDS, metastatic melanoma, and renal cell carcinoma.

Related Experiment Videos

  • Soluble IL-2 receptor shows potential as a diagnostic marker for autoimmune diseases.
  • IL-2 antagonism is used for immunosuppression.

    • Conclusions:

    • IL-2 is a versatile therapeutic agent for immune modulation.
    • Capillary leak syndrome is the primary adverse effect.
    • IL-2 is expected to be crucial in managing viral infections and malignancies.